
# OECD_486_dose with significant increase in positive cells	
# OECD_486_moribound or dead animals prior to study termination	
# OECD_486_cytotoxicity measurment	
# OECD_486_viability of cells	
# OECD_486_conclusion	
# OECD_486_homogeneity	
# OECD_486_pH	OECD_486_concentration (%)	OECD_486_composition	
# OECD_486_purity (%)	
# OECD_486_solubility in vehicle	
# OECD_486_chemical batch nr	
# OECD_486_Tmax	
# OECD_486_additional info	
# OECD_486_species/strain	
# OECD_486_source	
# OECD_486_sex	
# OECD_486_feed	
# OECD_486_n animals / group	
# OECD_486_dose levels	
# OECD_486_administration scheme	
# OECD_486_dose volume	
# OECD_486_oral	
# OECD_486_% of body surface	
# OECD_486_area of body	
# OECD_486_inhalation	
# OECD_486_intravenous	
# OECD_486_subcutaneous	
# OECD_486_vehicle	
# OECD_486_method of liver cell preparation and autoradiographic technique	
# OECD_486_time between sacrifice and last treatment (h)	
# OECD_486_number of cells scored	OECD_486_number of slides prepared	
# OECD_486_SCCS comment to test	
# OECD_486_year	
# OECD_486_GLP	
# OECD_486_Ref. in dossier	
# OECD_486_range-finding study	
# OECD_486_control groups